Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts

Biochemical Journal

Volumn 423, Issue 3, 2009, Pages 343-351

  Kiyan, Julia ^a   Smith, Graham ^b   Haller, Hermann ^a   Dumler, Inna ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Caveolin; Cell differentiation; Lipid raft; Platelet derived growth factor receptor (PDGFR); Urokinase type plasminogenactivator receptor (uPAR); Vascular smooth muscle cell

Indexed keywords

CAVEOLIN; CELL DIFFERENTIATION; LIPID RAFT; PLATELET-DERIVED GROWTH FACTOR-RECEPTOR (PDGFR); UROKINASE-TYPE PLASMINOGENACTIVATOR RECEPTOR (UPAR); VASCULAR SMOOTH MUSCLE CELL;

BIOACTIVITY; BLOOD SUBSTITUTES; BLOOD VESSEL PROSTHESES; CELL PROLIFERATION; CHEMICAL ACTIVATION; CHOLESTEROL; MACHINERY; MUSCLE; NUCLEIC ACIDS; PEPTIDES; PLATELETS; RNA;

CELL MEMBRANES;

CAVEOLIN 1; CHOLESTEROL; FILIPIN; METHYL BETA CYCLODEXTRIN; RNA; UROKINASE RECEPTOR;

ARTICLE; CAVEOLIN 1 DEFICIENCY; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; ENZYME REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIPID RAFT; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; RNA INTERFERENCE; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-CYCLODEXTRINS; CAVEOLIN 1; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; FILIPIN; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; MEMBRANE MICRODOMAINS; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; TRANSCRIPTION, GENETIC; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

MUS;

EID: 70350094711     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20090447     Document Type: Article

References (41)

1. Brown, M. S. and Goldstein, J. L. (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34-47
2. Simons, K. and Toomre, D. (2000) Lipid rafts and signal transduction. Nat. Rev. Mol. Cell. Biol. 1, 31-39
3. Zidovetzki, R. and Levitan, I. (2007) Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. Biochim. Biophys. Acta 1768, 1311-1324
4. Gimpl, G. and Gehrig-Burger, K. (2007) Cholesterol reporter molecules. Biosci. Rep. 27, 335-358
5. Lusis, A. J. (2000) Atherosclerosis. Nature 407, 233-241
6. Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809
7. Steins, M. B., Padro, T., Schwaenen, C., Ruiz, S., Mesters, R. M., Berdel, W. E. and Kienast, J. (2004) Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions. Blood Coagul. Fibrinolysis 15, 383-391
8. Salame, M. Y., Samani, N. J., Masood, I. and deBono, D. P. (2000) Expression of the plasminogen activator system in the human vascular wall. Atherosclerosis 152, 19-28
9. Okada, S. S., Golden, M. A., Raghunath, P. N., Tomaszewski, J. E., David, M. L., Kuo, A., Kariko, K. and Barnathan, E. S. (1998) Native atherosclerosis and vein graft arterialization: association with increased urokinase receptor expression in vitro and in vivo. Thromb. Haemostasis 80, 140-147
10. Blasi, F. and Carmeliet, P. (2002) uPAR: a versatile signalling orchestrator. Nat. Rev. Mol. Cell. Biol. 3, 932-943
11. Lamfers, M. L. M., Grimbergen, J. M., Aalders, M. C., Havenga, M. J., de Vries, M. R., Huisman, L. G. M., van Hinsbergh, V. W. and Quax, P. H. A. (2002) Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1. Circ. Res. 91, 945-952
12. Quax, P. H., Lamfers, M. L., Lardenoye, J. H., Grimbergen, J. M., de Vries, M. R., Slomp, J., de Ruiter, M. C., Kockx, M. M., Verheijen, J. H. and van Hinsbergh, V. W. (2001) Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels. Circulation 103, 562-569
13. Kiyan, Y., Kiyan, R., Haller, H. and Dumler, I. (2005) Urokinase-induced signaling in human vascular smooth muscle cells are mediated by PDGFR-β. EMBO J. 24, 1787-1797
14. Cunningham, O., Andolfo, A., Santovito, M. L., Iuzzolino, L., Blasi, F. and Sidenius, N. (2003) Dimerization controls the lipid rafts partitioning of uPAR/CD87 and regulates its biological functions. EMBO J. 22, 5994-6003
15. Sahores, M., Prinetti, A., Chiabrando, G., Blasi, F. and Sonnino, S. (2008) uPA binding increases uPAR localization to lipid rafts and modifies the receptor microdomain composition. Biochem. Biophys. Acta 1778, 250-259
16. Kiyan, J., Haller, H. and Dumler, I. (2009) The tyrosine phosphatase SHP-2 controls urokinase-dependent signaling and functions in human vascular smooth muscle cells. Exp. Cell Res. 315, 1029-1039
17. Reference deleted
18. Rong, J. X., Shapiro, M., Trogan, E. and Fisher, E. A. (2003) Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc. Natl. Acad. Sci. U.S.A. 100, 12531-13536
19. Thyberg, J. (2002) Caveolae and cholesterol distribution in vascular smooth muscle cells of different phenotypes. J. Histochem. Cytochem. 50, 185-195
20. Kiyan, J., Kusch, A., Tkachuk, S., Kramer, J., Dietz, R., Smith, G. and Dumler, I. (2007) Rosuvastatin regulates vascular smooth muscle cell phenotypic modulation in vascular remodeling: role for the urokinase receptor. Atheriosclerosis 195, 254-261
21. Fallier-Becker, P., Rupp, J., Fingerle, J. and Betz, E. (1990) Smooth muscle cells from rabbit aorta. In Cell Culture Techniques in Heart and Vessel Research (Piper, H. M., ed.), pp. 247-270, Springer-Verlag, Berlin
22. Kusch, A., Tkachuk, S., Lutter, S., Haller, H., Dietz, R., Lipp, M. and Dumler, I. (2002) Monocyte-expressed urokinase regulares human vascular smooth muscle cell migration in coculture model. Biol. Chem. 383, 217-221
23. Macdonald, J. L. and Pike, L. J. (2005) A simplified method for the preparation of detergent-free lipid rafts. J. Lipid Res. 46, 1061-1067
24. Stehr, M, Adam, R. M., Khoury, J., Zhuang, L., Solomon, K. R., Peters, C. A. and Freeman, M. R. (2003) Platelet derived growth factor-BB is a potent mitogen for rat ureteral and human bladder smooth muscle cells: dependence on lipid rafts for cell signaling. J. Urol. 169, 1165-1170
25. Gratton, J. P., Bernatchez, P. and Sessa, W. C. (2004) Caveolae and caveolins in the cardiovascular system. Circ. Res. 94, 1408-1417
26. Dopico, A. M. and Tigyi, G. J. (2007) A glance at the structural and functional diversity of membrane lipids. Methods Mol. Biol. 400, 1-13
27. Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C. et al. (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293, 2449-2452
28. Golub, T., Wacha, S. and Caroni, P. (2004) Spatial and temporal control of signaling through lipid rafts. Curr. Opin. Neurobiol. 14, 542-550
29. Michel, V. and Bakovic, M. (2007) Lipid rafts in health and disease. Biol. Cell. 99, 129-140
30. Patel, H. H. and Insel, P. A. (2009) Lipid rafts and caveolae and their role in compartmentation of redox signaling. Antioxid. Redox Signaling 11, 1357-1372
31. Li, X. A., Everson, W. V. and Smart, F. J. (2005) Caveolae, lipid rafts, and vascular disease. Trends Cardiovasc. Med. 15, 92-96
32. Lopez, J. A., Del Conde, I. and Shrimpton, C. N. (2005) Receptors, rafts, and microvesicles in thrombosis and inflammation. J. Thromb. Haemostasis 3, 1737-1744
33. Jury, E. C., Kabouridis, P. S., Flores-Borja, F., Mageed, R. A. and Isenberg, D. A. (2004) Altered lipid raft-associated signaling and ganlioside expression in T lymphocytes from patients with systemic lupus erythematosus. J. Clin. Invest. 113, 1176-1187
34. Besshoh, S., Bawa, D., Teves, L., Wallace, C. and Gurd, J. W. (2005) Increased phosphorylation and redistribution of NMDA receptors between synaptic lipid rafts and post-synaptic densities following transient global ischemia in the rat brain. J. Neurochem. 93, 186-194
35. Floto, R. A., Clatworthy, M. R., Heilbrronn, K. R., Rosner, D. R., Macary, P. A., Rankin, A., Lehner, P. J., Ouwehand, W. H., Allen, J. M., Watkins, N. A. and Smith, K. G. (2005) Loss of function of a lupus-associated Fcγ RIIb polymorphism through exclusion from lipid rafts. Nat. Med. 11, 1056-1058
36. Allsup, D. J., Kamiguti, A. S., Lin, K., Sherrington, P. D., Matrai, Z., Slupsky, J. R., Cawley, J. C. and Zuzel, M. (2005) B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia. Cancer Res. 65, 7328-7337
37. Carmeliet, P., Moons, L., Herbert, J. M., Crawley, J., Lupu, F., Lijnen, R. and Collen, D. (1997) Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circ. Res. 99, 200-208
38. Clowes, A. W., Clowes, M. M., Au, Y. P., Reidy, M. A. and Belin, D. (1990) Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ. Res. 67, 61-67
39. Roelofs, J. J. T. H., Rowshani, A. T., Van den Berg, J. G., Claessen, N., Aten, J., Ten Berge, I. J. M., Weening, J. J. and Florquin, S. (2003) Expresssion of urokinase plasminogen activator and its receptor during acute renal allograft rejection. Kidney Int. 64, 1845-1853
40. Sargiacomo, M., Sudol, M., Tang, Z. and Lisanti, M. P. (1993) Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J. Cell Biol. 122, 789-807
41. Kiian, I., Tkachuk, N., Haller, H. and Dumler, I. (2003) Urokinase-induced migration of human vascular smooth muscle cells requires coupling of the small GTPases RhoA and Rac1 to the Tyk2/PI3-K signalling pathway. Thromb. Haemostasis 89, 904-914